Centuple Global Ltd

NSE: RUBRAME · BSE: 531099 · Pharmaceuticals & Biotechnology · 27 announcements

Share price: ₹32.16
Market cap: ₹17.59 Cr
Revenue (annual): ₹573.8 Cr
Net profit (annual): ₹1.51 Cr
P/E (TTM): 14.2×Sector 43.8×
Promoter holding: 0.00%+0.00% QoQ
FII holding: 19.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

6 Nov 2026 18:55 IST BSE

Board Meeting Date

Centuple Global Board Meeting Date

Centuple Global gives prior intimation of a board meeting on 13 November 2026 to consider unaudited standalone half-year financial results. The filing carries no financial figures or business decision.

Open announcement → Read the filing ↗

13 Oct 2026 16:58 IST BSE

Annual General Meeting

Centuple Global Annual General Meeting

Centuple Global Limited issued a Postal Ballot Notice seeking shareholder approval for the appointment of statutory auditors and a change in director's designation.

Open announcement → Read the filing ↗

13 Oct 2026 10:57 IST BSE

Other Announcement

Centuple Global Other Announcement

Centuple Global Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.

Open announcement → Read the filing ↗